Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Regor Pharmaceuticals Inc.
Regor Pharmaceuticals Inc.
Seagen Inc.
Eli Lilly and Company
Kivu Bioscience Inc.
Genentech, Inc.
Eli Lilly and Company
OncoC4, Inc.
Kortuc, Inc.
KaliVir Immunotherapeutics
Arcus Biosciences, Inc.
Radiopharm Theranostics, Ltd
Sotio Biotech Inc.
SystImmune Inc.
Rondo Therapeutics
Orano Med LLC
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
Alterome Therapeutics, Inc.
Sutro Biopharma, Inc.
ViroMissile, Inc.
AbbVie
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Eli Lilly and Company
Fusion Pharmaceuticals Inc.
Innate Pharma
Dren Bio
OncoNano Medicine, Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
Therorna
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Nurix Therapeutics, Inc.
Pfizer
Arcus Biosciences, Inc.
Adcentrx Therapeutics
Incyte Corporation
AstraZeneca
NextPoint Therapeutics, Inc.
HC Biopharma Inc.
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Exelixis
Seagen Inc.